Global Panoramic analysis of clinical research in cell therapy: clinical trial landscape, marketed products, and regulatory trends
These findings reveal distinct regional strengths and strategic emphases in cell therapy development. The observed patterns are significantly influenced by heterogeneous regulatory frameworks across regions. The global industry is advancing the translation of cell therapy from cutting-edge technology to accessible clinical application through the synergy of scientific innovation and evolving regulatory pathways.
Authors
- Xiaoqiong Zhang (ORCID: https://orcid.org/0009-0007-2849-497X)
- Minglong Chen (ORCID: https://orcid.org/0000-0002-9844-486X)
- Wenxin Hu (ORCID: https://orcid.org/0000-0002-0330-5200)
- Tao Zhou (ORCID: https://orcid.org/0000-0002-6507-8912)
- Kang Xie (ORCID: https://orcid.org/0000-0001-8832-3215)
- Jiancai Wu
- Wanwan Xiang
- Mengmeng Wang
- Sijia Liu
- Xi Wang
- Mengling Fang
- Ziyue Zhang
Institutions
- Foundation University (PH)
- Union Hospital (CN)
- Columbia University (US)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-02-09
- DOI
- https://doi.org/10.3389/fphar.2026.1715984
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00